Search Results - "Wexelblatt, Scott L"

Cohort Analysis of a Pharmacokinetic-Modeled Methadone Weaning Optimization for Neonatal Abstinence Syndrome by Hall, Eric S., PhD, Meinzen-Derr, Jareen, PhD, Wexelblatt, Scott L., MD

“…Objective To evaluate neonatal abstinence syndrome (NAS) treatment outcomes achieved using an optimized methadone weaning protocol developed using…”
Get full text

A Cohort Comparison of Buprenorphine versus Methadone Treatment for Neonatal Abstinence Syndrome by Hall, Eric S., PhD, Isemann, Barbara T., BSPharm, Wexelblatt, Scott L., MD, Meinzen-Derr, Jareen, PhD, Wiles, Jason R., MD, Harvey, Sharon, BSN, Akinbi, Henry T., MD

“…Objectives To compare the duration of opioid treatment and length of stay among infants treated for neonatal abstinence syndrome (NAS) by using a pilot…”
Get full text

Forecasting Fetal Buprenorphine Exposure through Maternal-Fetal Physiologically Based Pharmacokinetic Modeling by van Hoogdalem, Matthijs W, Tanaka, Ryota, Abduljalil, Khaled, Johnson, Trevor N, Wexelblatt, Scott L, Akinbi, Henry T, Vinks, Alexander A, Mizuno, Tomoyuki

“…Buprenorphine readily crosses the placenta, and with greater prenatal exposure, neonatal opioid withdrawal syndrome (NOWS) likely grows more severe. Current…”
Get full text

Universal Maternal Drug Testing in a High-Prevalence Region of Prescription Opiate Abuse by Wexelblatt, Scott L., MD, Ward, Laura P., MD, Torok, Kimberly, RN, Tisdale, Elizabeth, RN, NNP, Meinzen-Derr, Jareen K., PhD, Greenberg, James M., MD

“…Objective To evaluate the efficacy of a universal maternal drug testing protocol for all mothers in a community hospital setting that experienced a 3-fold…”
Get full text

A review of pregnancy-induced changes in opioid pharmacokinetics, placental transfer, and fetal exposure: Towards fetomaternal physiologically-based pharmacokinetic modeling to improve the treatment of neonatal opioid withdrawal syndrome by van Hoogdalem, Matthijs W., Wexelblatt, Scott L., Akinbi, Henry T., Vinks, Alexander A., Mizuno, Tomoyuki

“…Physiologically-based pharmacokinetic (PBPK) modeling has emerged as a useful tool to study pharmacokinetics (PK) in special populations, such as pregnant…”
Get full text

A multicenter cohort study of treatments and hospital outcomes in neonatal abstinence syndrome by Hall, Eric S, Wexelblatt, Scott L, Crowley, Moira, Grow, Jennifer L, Jasin, Lisa R, Klebanoff, Mark A, McClead, Richard E, Meinzen-Derr, Jareen, Mohan, Vedagiri K, Stein, Howard, Walsh, Michele C

“…To compare pharmacologic treatment strategies for neonatal abstinence syndrome (NAS) with respect to total duration of opioid treatment and length of inpatient…”
Get full text

Developmental Disorders and Medical Complications Among Infants with Subclinical Intrauterine Opioid Exposures by Hall, Eric S, McAllister, Jennifer M, Wexelblatt, Scott L

“…The objective was to compare diagnosis rates representing developmental outcomes and medical complications between infants with intrauterine opioid exposures…”
Get more information

Subclinical and Overt Newborn Opioid Exposure: Prevalence and First-Year Healthcare Utilization by Percy, Zana, Brokamp, Cole, McAllister, Jennifer M., Ryan, Patrick, Wexelblatt, Scott L., Hall, Eric S.

“…To categorize newborn infants in Hamilton County, Ohio by late pregnancy fetal opioid exposure status and to assess their first-year healthcare utilization. We…”
Get full text

Implementation of a Neonatal Abstinence Syndrome Weaning Protocol: A Multicenter Cohort Study by Hall, Eric S, Wexelblatt, Scott L, Crowley, Moira, Grow, Jennifer L, Jasin, Lisa R, Klebanoff, Mark A, McClead, Richard E, Meinzen-Derr, Jareen, Mohan, Vedagiri K, Stein, Howard, Walsh, Michele C

“…To evaluate the generalizability of stringent protocol-driven weaning in improving total duration of opioid treatment and length of inpatient hospital stay…”
Get full text

Physiologically‐Based Pharmacokinetic Modeling to Investigate the Effect of Maturation on Buprenorphine Pharmacokinetics in Newborns with Neonatal Opioid Withdrawal Syndrome by van Hoogdalem, Matthijs W., Johnson, Trevor N., McPhail, Brooks T., Kamatkar, Suyog, Wexelblatt, Scott L., Ward, Laura P., Christians, Uwe, Akinbi, Henry T., Vinks, Alexander A., Mizuno, Tomoyuki

“…Neonatal opioid withdrawal syndrome (NOWS) is a major public health concern whose incidence has paralleled the opioid epidemic in the United States. Sublingual…”
Get full text

Racial Inequities in Breastfeeding Counseling Among Pregnant People Who Use Cannabis by Nidey, Nichole, Hoyt-Austin, Adrienne, Chen, Melissa J., Bentley, Brandie, Tabb, Karen M., Anyigbo, Chidiogo, Wilder, Christine, Terplan, Mishka, McAllister, Jennifer M., Wexelblatt, Scott L., Murnan, Aaron, Kair, Laura R.

“…We examined how breastfeeding advice in the context of cannabis use differed by race and ethnicity. Data from the 2017–2018 PRAMS (Pregnancy Risk Assessment…”
Get full text

Rates of substance and polysubstance use through universal maternal testing at the time of delivery by Smith, Brittany L., Hall, Eric S., McAllister, Jennifer M., Marcotte, Michael P., Setchell, Kenneth D. R., Megaraj, Vandana, Jimenez, Kristine L., John Winhusen, T., Wexelblatt, Scott L.

“…Objective To report substance and polysubstance use at the time of delivery. Study design A cross-sectional study was performed on mothers consented for…”
Get full text

Pharmacotherapy of neonatal opioid withdrawal syndrome: a review of pharmacokinetics and pharmacodynamics by van Hoogdalem, Matthijs W, McPhail, Brooks T, Hahn, David, Wexelblatt, Scott L, Akinbi, Henry T, Vinks, Alexander A, Mizuno, Tomoyuki

“…Neonatal opioid withdrawal syndrome (NOWS) often arises in infants born to mothers who used opioids during pregnancy. Morphine, methadone, and buprenorphine…”
Get more information

Opioid Neonatal Abstinence Syndrome: An Overview by Wexelblatt, Scott L., McAllister, Jennifer M., Nathan, Amy T., Hall, Eric S.

“…Opioid neonatal abstinence syndrome (NAS) refers to signs of withdrawal observed in infants experiencing intrauterine opioid exposures. Early identification of…”
Get full text

Regional comparison of self-reported late pregnancy cigarette smoking to mass spectrometry analysis by Hall, Eric S., McAllister, Jennifer M., Kelly, Elizabeth A., Setchell, Kenneth D. R., Megaraj, Vandana, Jimenez, Kristine L., Nidey, Nichole, Greenberg, James M., Wexelblatt, Scott L.

“…Objective To report a more accurate prevalence estimate of late pregnancy nicotine exposures. Study design A cross-sectional study during a 2-month period in…”
Get full text

Torticollis in Infants with a History of Neonatal Abstinence Syndrome by McAllister, Jennifer M., Hall, Eric S., Hertenstein, Gayle E.R., Merhar, Stephanie L., Uebel, Patricia L., Wexelblatt, Scott L.

“…In this retrospective cohort study, we assessed the incidence of torticollis in infants with a history of neonatal abstinence syndrome. Understanding the…”
Get full text

Comparison of Neonatal Abstinence Syndrome Treatment with Sublingual Buprenorphine versus Conventional Opioids by Hall, Eric S, Rice, Ward R, Folger, Alonzo T, Wexelblatt, Scott L

“…The objective of this study was to compare duration of opioid treatment and length of stay outcomes for neonatal abstinence syndrome (NAS) using sublingual…”
Get more information

Addressing the Disease Burden of Vertically Acquired Hepatitis C Virus Infection Among Opioid-Exposed Infants by Protopapas, Stella, Murrison, Liza Bronner, Wexelblatt, Scott L, Blackard, Jason T, Hall, Eric S

“…This study aims to estimate the disease burden of vertically acquired hepatitis C virus (HCV) in a large Midwestern hospital and to identify factors associated…”
Get full text

Care Coordination Associated with Improved Timing of Newborn Primary Care Visits by Goyal, Neera K., Hall, Eric S., Kahn, Robert S., Wexelblatt, Scott L., Greenberg, James M., Samaan, Zeina M., Brown, Courtney M.

“…Objective Despite practice recommendations that all newborns be examined within 3–5 days after discharge, many are not seen within this timeframe. Our…”
Get full text

Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment for opioid dependence in pregnancy and for neonatal abstinence syndrome by Winhusen, Theresa, Wilder, Christine, Wexelblatt, Scott L, Theobald, Jeffrey, Hall, Eric S, Lewis, Daniel, Van Hook, James, Marcotte, Michael

“…Abstract Rationale In recent years, the U.S. has experienced a significant increase in the prevalence of pregnant opioid-dependent women and of neonatal…”
Get full text